Which baseline blood markers does this article tie to fatigue risk
Careful attention to timing, severity, and symptom progression helps clinicians distinguish benign side effects from those requiring discontinuation or referral
Animal studies serve an important role in identifying potential concerns that warrant human investigation
McCoy The cohort included 351,913 adults aged 21 years and older with type 2 diabetes and moderate risk for CVD who filled an initial prescription for a GLP-1 drug , SGLT2 inhibitor, DPP-IV inhibitor or sulfonylurea from 2014 to 2021 (mean age, 65.3 years
Future surveillance frameworks should prioritize multinational data harmonization and integration with real-world evidence streams to enhance validity
3,130,219 GLP-1 also activates PKA and EPAC through a cAMP-dependent pathway